• Molecular NameAcipimox
  • SynonymNA
  • Weight154.125
  • Drugbank_IDN/A
  • ACS_NO51037-30-0
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)0.64
  • pkaN/A
  • LogD (pH=7, predicted)-2.91
  • Solubility (experiment)9.95 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)0.81
  • LogSw (predicted, AB/LogsW2.0)116.09
  • Sw (mg/ml) (predicted, ACD/Labs)314.84
  • No.of HBond Donors1
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds1
  • TPSA75.65
  • StatusN/A
  • AdministrationN/A
  • PharmacologyA niacin derivative used as a hypolipidemic agent.
  • Absorption_value95.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability90.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A